Sophia Genetics Sa (SOPH)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1108)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, BTSG, TEM, HQY, HNGE

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOPH Sophia Genetics Sa	4.88	362.54M	81.18M	-80.94M	-55.15M	-1.1809
VEEV Veeva Systems Inc	160.17	25.83B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	58.50	11.25B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	46.18	8.35B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	88.11	7.25B	1.31B	215.20M	408.32M	2.4627
HNGE Hinge Health Inc	55.25	4.27B	646.34M	-512.40M	202.76M	-6.6871

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-18	Eingeleitet	Craig Hallum	Buy
2024-08-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Eingeleitet	Guggenheim	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-03	Eingeleitet	BTIG Research	Buy
2022-11-23	Eingeleitet	Credit Suisse	Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-17	Eingeleitet	Cowen	Outperform
2021-08-17	Eingeleitet	Credit Suisse	Outperform
2021-08-17	Eingeleitet	JP Morgan	Overweight
2021-08-17	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Compare SOPH vs VEEV, BTSG, TEM, HQY, HNGE

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Undervalued Opportunities: Top Penny Stocks To Watch In May 2026 - Sahm

SOPHiA GENETICS (SOPH) president’s 761-share tax sale under 10b5-1 plan - Stock Titan

SOPHiA GENETICS (SOPH) CSO sells shares to cover RSU tax via 10b5-1 plan - Stock Titan

[Form 4] SOPHiA GENETICS SA Insider Trading Activity - Stock Titan

SOPHiA GENETICS (SOPH) CMO pre-planned sale of 608 shares for tax - Stock Titan

Tax-driven sale: SOPHiA GENETICS (SOPH) CLO disposes 684 shares - Stock Titan

SOPHiA GENETICS (SOPH) CPO sells 380 shares to cover RSU taxes - Stock Titan

SOPHiA GENETICS (SOPH) CSO sells 33 shares in tax sell-to-cover - Stock Titan

JURGI CAMBLONG sells shares under 10b5-1 (SOPH) - Stock Titan

Manuela Valente files Form 144 to sell SOPH shares (NASDAQ: SOPH) - Stock Titan

SOPH (NASDAQ) insider RSUs recorded; Philippe Menu reports multiple 10b5-1 sales - Stock Titan

761 RSUs filed; prior 10b5-1 sales by Ross J Muken (SOPH) - Stock Titan

Form 144: 684 RSUs flagged for sale by Morgan Stanley Smith Barney (SOPH) - Stock Titan

Rule 144: Officer/holder lists 4,608 RSUs for sale (SOPH) - Stock Titan

SOPHiA GENETICS Files Form 6-K and Publishes 2025 ESG Impact Summary - TipRanks

SOPHiA GENETICS (SOPH) publishes 2025 ESG Impact Summary for investors - Stock Titan

SOPHiA GENETICS (SOPH) CSO executes 4,000-share sale under 10b5-1 plan - Stock Titan

Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA - GuruFocus

Director Kathy Hibbs sells SOPHiA GENETICS (SOPH) shares under 10b5-1 plan - Stock Titan

SOPHiA GENETICS (SOPH) CMO pre-planned sale of 5,000 shares - Stock Titan

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. - marketscreener.com

New NHS blood test aims to speed lung and breast cancer treatment - Stock Titan

SOPHiA Genetics inks two deals to advance AI for precision medicine - MSN

SOPHiA GENETICS (SOPH) CEO 10b5-1 sale of 8,500 shares - Stock Titan

TradingKey - tradingkey.com

How SOPHiA (SOPH) performance reflects its true potential (-4.63%) 2026-05-08Macro Trends - Newser

SOPHiA GENETICS schedules annual general meeting for June 18 in Switzerland - Investing.com Nigeria

SOPHiA GENETICS schedules annual general meeting for June 18 in Switzerland By Investing.com - Investing.com South Africa

SOPHiA GENETICS Calls 2026 AGM as It Highlights Breakout 2025 Growth - TipRanks

Leadership change and pay votes at SOPHiA GENETICS (Nasdaq: SOPH) - Stock Titan

SOPHiA GENETICS SA 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-05-07 - Seeking Alpha

SOPHiA GENETICS (NASDAQ:SOPH) Earns Buy Rating from BTIG Research - MarketBeat

SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q1 2026 Earnings Call Transcript - Insider Monkey

BTIG reiterates Sophia Genetics stock rating on strong Q1 growth - Investing.com UK

BTIG reiterates Sophia Genetics stock rating on strong Q1 growth By Investing.com - Investing.com Australia

SOPHiA GENETICS Earnings Call: Growth With Caveats - TipRanks

SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary - Yahoo Finance

SOPHiA GENETICS Q1 Earnings Call Highlights - MarketBeat

SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript - AOL.com

SOPHiA GENETICS (NASDAQ:SOPH) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat

SOPH: Q1 revenue up 22%, record platform usage, and strong margin; 2026 guidance reaffirmed - TradingView

SOPHiA GENETICS SA reports results for the quarter ended March 31Earnings Summary - TradingView

BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8 - Insider Monkey

SOPHiA GENETICS Posts Higher Q1 2026 Revenue but Wider Loss in Newly Filed Form 6-K - TipRanks

SOPH: Q1 2026 revenue up 22% year-over-year, with improved margins and strong global expansion - TradingView

SOPHiA GENETICS Reports First Quarter 2026 Results - ChartMill

SOPHiA GENETICS (SOPH) grows Q1 2026 revenue 22% but remains loss-making - Stock Titan

How SOPHiA (SOPH) responds to market challenges (Technical Weakness) 2026-05-05Pre-Earnings Momentum - Newser

SOPHiA GENETICS SA expected to post a loss of 23 cents a shareEarnings Preview - TradingView

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,100.00 in Stock - MarketBeat

SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under 10b5-1 plan - Stock Titan

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SOPH